Patrick Smith Ceo Curaxis Pharmaceutical Corporation - Alzheimer Disease

http://blog.curaxispharma.com
Patrick Smith (919)749-0049
psmith@curaxispharma.com
.
Patrick Smith, CEO of Curaxis Pharmaceutical Corporation, is the leader in developing a disease modifying treatment for Alzheimer Disease which is the most common form of dementia (a brain disorder that seriously affects a person's ability to carry out daily activities) among older people.

Patrick Smith has over 35 years in the health care industry. There are over 35M people who currently suffer from this degenerative brain disease (not including the family caregivers and nursing homes involved) with expectation to reach over 115M by 2050.

In 1999, Curaxis management team began the process of a new theory for many of the diseases of aging. Alzheimer Disease became the primary focus in terms of developing a drug for this disease.

Curaxis is positioned to offer a treatment for Alzheimer Disease that has been in preclinical, basic science research and human clinical FDA approved trials over the last 10 years and is now moving into the final stages up to commercialization.

Curaxis drug is disease modifying as it stops the underlying pathologies of Alzheimer Disease as opposed to treating the symptoms of it. It is the only drug on the market for the treatment of Alzheimer Disease.

Patrick Smith's Curaxis Pharmaceutical Corp is the company that is making a contribution to society that will be as impactful as this drug promises to be on Alzheimer Disease. This is a huge financial investment opportunity for those involved with bringing a commercialized, disease modifying drug to the market to cure Alzheimer's Disease.

Curaxis' strategy is to initiate enrollment and dose the first patient in a Phase II clinical trial in women with mild to moderate Alzheimer's Disease in 2010. This major step will signify the next stage in the development of Curaxis Pharmaceutical and a major milestone towards commercialization of Curaxis treatment for Alzheimer's Disease.

To learn more view the video on Curaxis Blog http://blog.curaxispharma.com/media . This video includes a general overview of current state of the disease; how it affects our society as well its development and the relationship between the HPG Axis and the human growth cycle. It explains the platform for Curaxis science and how Curaxis research offers hope to the millions of lives affected by Alzheimer's Disease.

Contact Patrick Smith (919)749-0049 psmith@curaxispharma.com

Category:

Science & Technology

Tags:

• Patrick
• Smith
• Curaxis
• Pharmaceutical
• Corporation
• Alzheimer's Disease
• medicine
• research
• pharmaceutical
• Southridge
• Research
• Group
• institutional research
• investment banking
• banking
• investments
• wealth
• strategies
• wealth management
• wealth strategies
• Equity
• Asset-based lending
• quantitative methods
• structured
• finance
• investment
• opportunities